The adaptive immune system in atopic dermatitis and implications on therapy

References

• Werfel T, Schwerk N, Hansen G, et al. The diagnosis and graded therapy of atopic dermatitis. Dtsch Arztebl Int. 2014;111(29–30):509–520.
   PubMed Web of Science ®Google Scholar
• Ring J, Mohrenschlager M, Weidinger S. Molecular genetics of atopic eczema. Chem Immunol Allergy. 2012;96:24–29.
   PubMedGoogle Scholar
• Czarnowicki T, Malajian D, Shemer A, et al. Skin-homing and systemic T-cell subsets show higher activation in atopic dermatitis versus psoriasis. J Allergy Clin Immunol. 2015;136(1):208–211.
   PubMed Web of Science ®Google Scholar
• Breuer K, Heratizadeh A, Wulf A, et al. Late eczematous reactions to food in children with atopic dermatitis. Clin Exp Allergy. 2004;34(5):817–824.
   PubMed Web of Science ®Google Scholar
• Heratizadeh A, Wichmann K, Werfel T. Food allergy and atopic dermatitis: how are they connected? Curr Allergy Asthma Rep. 2011;11(4):284–291.
   PubMed Web of Science ®Google Scholar
• Reekers R, Busche M, Wittmann M, et al. Birch pollen-related foods trigger atopic dermatitis in patients with specific cutaneous T-cell responses to birch pollen antigens. J Allergy Clin Immunol. 1999;104(2 Pt 1):466–472.
   PubMed Web of Science ®Google Scholar
• Custovic A, Sonntag HJ, Buchan IE, et al. Evolution pathways of IgE responses to grass and mite allergens throughout childhood. J Allergy Clin Immunol. 2015;136(6):1645–1652.e8.
   PubMed Web of Science ®Google Scholar
• Turjanmaa K, Darsow U, Niggemann B, et al. EAACI/GA(2)LEN position paper: present status of the atopy patch test. Allergy. 2006;61(12):1377–1384.
   PubMed Web of Science ®Google Scholar
• Darsow U, Laifaoui J, Kerschenlohr K, et al. The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy. 2004;59(12):1318–1325.
   PubMed Web of Science ®Google Scholar
• Tupker RA, De Monchy JG, Coenraads PJ, et al. Induction of atopic dermatitis by inhalation of house dust mite. J Allergy Clin Immunol. 1996;97(5):1064–1070.
   PubMed Web of Science ®Google Scholar
• Werfel T, Heratizadeh A, Aberer W, et al. S2k guideline on diagnosis and treatment of atopic dermatitis – short version. J Dtsch Dermatol Ges. 2016;14(1):92–105.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Resch Y, Chen KW, et al. Der p 11 is a major allergen for house dust mite-allergic patients suffering from atopic dermatitis. J Invest Dermatol. 2015;135(1):102–109.
   PubMed Web of Science ®Google Scholar
• Weghofer M, Thomas WR, Kronqvist M, et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest. 2008;38(12):959–965.
   PubMed Web of Science ®Google Scholar
• Batard T, Baron-Bodo V, Martelet A, et al. Patterns of IgE sensitization in house dust mite-allergic patients: implications for allergen immunotherapy. Allergy. 2015;71(2):220–229.
   PubMed Web of Science ®Google Scholar
• Dumez ME, Herman J, Campizi V, et al. Orchestration of an uncommon maturation cascade of the house dust mite protease allergen quartet. Front Immunol. 2014;5:138.
   PubMed Web of Science ®Google Scholar
• Szalai K, Kopp T, Lukschal A, et al. Establishing an allergic eczema model employing recombinant house dust mite allergens Der p 1 and Der p 2 in BALB/c mice. Exp Dermatol. 2012;21(11):842–846.
   PubMed Web of Science ®Google Scholar
• Landheer J, Giovannone B, Sadekova S, et al. TSLP is differentially regulated by vitamin D3 and cytokines in human skin. Immun Inflamm Dis. 2015;3(1):32–43.
   PubMed Web of Science ®Google Scholar
• Novak N, Bieber T, Hoffmann M, et al. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130(4):925–931e924.
   PubMed Web of Science ®Google Scholar
• Roesner LM, Heratizadeh A, Begemann G, et al. Der p1 and Der p2-specific T cells display a Th2, Th17, and Th2/Th17 phenotype in atopic dermatitis. J Invest Dermatol. 2015;135(9):2324–2327.
   PubMed Web of Science ®Google Scholar
• Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199(11):1567–1575.
   PubMed Web of Science ®Google Scholar
• Cosmi L, Maggi L, Santarlasci V, et al. Identification of a novel subset of human circulating memory CD4(+) T cells that produce both IL-17A and IL-4. J Allergy Clin Immunol. 2010;125(1):222–230 e221–224.
   PubMed Web of Science ®Google Scholar
• Wang YH, Voo KS, Liu B, et al. A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma. J Exp Med. 2010;207(11):2479–2491.
   PubMed Web of Science ®Google Scholar
• Wambre E, Bonvalet M, Bodo VB, et al. Distinct characteristics of seasonal (Bet v 1) vs. perennial (Der p 1/Der p 2) allergen-specific CD4(+) T cell responses. Clin Exp Allergy. 2011;41(2):192–203.
   PubMed Web of Science ®Google Scholar
• Hammad H, Chieppa M, Perros F, et al. House dust mite allergen induces asthma via toll-like receptor 4 triggering of airway structural cells. Nat Med. 2009;15(4):410–416.
   PubMed Web of Science ®Google Scholar
• Reynolds JM, Pappu BP, Peng J, et al. Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity. 2010;32(5):692–702.
   PubMed Web of Science ®Google Scholar
• Barrett NA, Rahman OM, Fernandez JM, et al. Dectin-2 mediates Th2 immunity through the generation of cysteinyl leukotrienes. J Exp Med. 2011;208(3):593–604.
   PubMed Web of Science ®Google Scholar
• Parsons MW, Li L, Wallace AM, et al. Dectin-2 regulates the effector phase of house dust mite-elicited pulmonary inflammation independently from its role in sensitization. J Immunol. 2014;192(4):1361–1371.
   PubMed Web of Science ®Google Scholar
• Kramer U, Weidinger S, Darsow U, et al. Seasonality in symptom severity influenced by temperature or grass pollen: results of a panel study in children with eczema. J Invest Dermatol. 2005;124(3):514–523.
   PubMed Web of Science ®Google Scholar
• Darsow U, Ring J. [Atopy patch testing with aeroallergens and food]. Hautarzt. 2005;56(12):1133–1140.
   PubMed Web of Science ®Google Scholar
• Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96–103e109.
   PubMed Web of Science ®Google Scholar
• Jinnestal CL, Belfrage E, Back O, et al. Skin barrier impairment correlates with cutaneous Staphylococcus aureus colonization and sensitization to skin-associated microbial antigens in adult patients with atopic dermatitis. Int J Dermatol. 2014;53(1):27–33.
   PubMed Web of Science ®Google Scholar
• Till SJ, Francis JN, Nouri-Aria K, et al. Mechanisms of immunotherapy. J Allergy Clin Immunol. 2004;113(6):1025–1034; quiz 1035.
   PubMed Web of Science ®Google Scholar
• Mobs C, Ipsen H, Mayer L, et al. Birch pollen immunotherapy results in long-term loss of Bet v 1-specific TH2 responses, transient TR1 activation, and synthesis of IgE-blocking antibodies. J Allergy Clin Immunol. 2012;130(5):1108–1116 e1106.
   PubMed Web of Science ®Google Scholar
• Wambre E, DeLong JH, James EA, et al. Differentiation stage determines pathologic and protective allergen-specific CD4+ T-cell outcomes during specific immunotherapy. J Allergy Clin Immunol. 2012;129(2):544–551, 551 e541–547.
   PubMed Web of Science ®Google Scholar
• Archila LD, DeLong JH, Wambre E, et al. Grass-specific CD4(+) T-cells exhibit varying degrees of cross-reactivity, implications for allergen-specific immunotherapy. Clin Exp Allergy. 2014;44(7):986–998.
   PubMed Web of Science ®Google Scholar
• Till SJ, Raynsford EJ, Reynolds CJ, et al. Peptide-induced immune regulation by a promiscuous and immunodominant CD4T-cell epitope of Timothy grass pollen: a role of Cbl-b and Itch in regulation. Thorax. 2014;69(4):335–345.
   PubMed Web of Science ®Google Scholar
• Wambre E, Delong JH, James EA, et al. Specific immunotherapy modifies allergen-specific CD4(+) T-cell responses in an epitope-dependent manner. J Allergy Clin Immunol. 2014;133(3):872–879e877.
   PubMed Web of Science ®Google Scholar
• Van Overtvelt L, Wambre E, Maillere B, et al. Assessment of Bet v 1-specific CD4+ T cell responses in allergic and nonallergic individuals using MHC class II peptide tetramers. J Immunol. 2008;180(7):4514–4522.
   PubMed Web of Science ®Google Scholar
• Mobs C, Slotosch C, Loffler H, et al. Birch pollen immunotherapy leads to differential induction of regulatory T cells and delayed helper T cell immune deviation. J Immunol. 2010;184(4):2194–2203.
   PubMed Web of Science ®Google Scholar
• Roesner LM, Floess S, Witte T, et al. Foxp3 regulatory T cells are expanded in severe atopic dermatitis patients. Allergy. 2015;70(12):1656–1660.
   PubMed Web of Science ®Google Scholar
• Baron U, Floess S, Wieczorek G, et al. DNA demethylation in the human FOXP3 locus discriminates regulatory T cells from activated FOXP3(+) conventional T cells. Eur J Immunol. 2007;37(9):2378–2389.
   PubMed Web of Science ®Google Scholar
• Hinz D, Bauer M, Roder S, et al. Cord blood Tregs with stable FOXP3 expression are influenced by prenatal environment and associated with atopic dermatitis at the age of one year. Allergy. 2012;67(3):380–389.
   PubMed Web of Science ®Google Scholar
• Schaub B, Liu J, Hoppler S, et al. Maternal farm exposure modulates neonatal immune mechanisms through regulatory T cells. J Allergy Clin Immunol. 2009;123(4):774–782e775.
   PubMedGoogle Scholar
• Noh J, Noh G, Kim HS, et al. Allergen-specific responses of CD19(+)CD5(+)Foxp3(+) regulatory B cells (Bregs) and CD4(+)Foxp3(+) regulatory T cell (Tregs) in immune tolerance of cow milk allergy of late eczematous reactions. Cell Immunol. 2012;274(1–2):109–114.
   PubMed Web of Science ®Google Scholar
• Lee JH, Noh J, Noh G, et al. Allergen-specific transforming growth factor-beta-producing CD19+CD5+ regulatory B-cell (Br3) responses in human late eczematous allergic reactions to cow’s milk. J Interferon Cytokine Res. 2011;31(5):441–449.
   PubMed Web of Science ®Google Scholar
• Bremmer SF, Simpson EL. Dust mite avoidance for the primary prevention of atopic dermatitis: A systematic review and meta-analysis. Pediatr Allergy Immunol. 2015;26(7):646–654.
   PubMed Web of Science ®Google Scholar
• Campana R, Moritz K, Marth K, et al. Frequent occurrence of T cell-mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments. J Allergy Clin Immunol. 2015;137(2):601–609.e8.
   PubMed Web of Science ®Google Scholar
• Focke-Tejkl M, Weber M, Niespodziana K, et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2015;135(5):1207–1207 e1201–1211.
   PubMed Web of Science ®Google Scholar
• Niederberger V, Marth K, Eckl-Dorna J, et al. Skin test evaluation of a novel peptide carrier-based vaccine, BM32, in grass pollen-allergic patients. J Allergy Clin Immunol. 2015;136(4):1101–1103 e1108.
   PubMed Web of Science ®Google Scholar
• Heil PM, Maurer D, Klein B, et al. Omalizumab therapy in atopic dermatitis: depletion of IgE does not improve the clinical course – a randomized, placebo-controlled and double blind pilot study. J Dtsch Dermatol Ges. 2010;8(12):990–998.
   PubMed Web of Science ®Google Scholar
• Werfel T, Biedermann T. Current novel approaches in systemic therapy of atopic dermatitis: specific inhibition of cutaneous Th2 polarized inflammation and itch. Curr Opin Allergy Clin Immunol. 2015;15(5):446–452.
   PubMed Web of Science ®Google Scholar
• Beck LA, Thaci D, Hamilton JD, et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis. N Engl J Med. 2014;371(2):130–139.
   PubMed Web of Science ®Google Scholar
• Howell MD, Parker ML, Mustelin T, et al. Past, present, and future for biologic intervention in atopic dermatitis. Allergy. 2015;70(8):887–896.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xiao C, Gibson AM, et al. EGFR signaling blunts allergen-induced IL-6 production and Th17 responses in the skin and attenuates development and relapse of atopic dermatitis. J Immunol. 2014;192(3):859–866.
   PubMed Web of Science ®Google Scholar
• Wichmann K, Uter W, Weiss J, et al. Isolation of alpha-toxin-producing Staphylococcus aureus from the skin of highly sensitized adult patients with severe atopic dermatitis. Br J Dermatol. 2009;161(2):300–305.
   PubMed Web of Science ®Google Scholar
• Breuer K, Wittmann M, Bosche B, et al. Severe atopic dermatitis is associated with sensitization to staphylococcal enterotoxin B (SEB). Allergy. 2000;55(6):551–555.
   PubMed Web of Science ®Google Scholar
• Breuer K, Wittmann M, Kempe K, et al. Alpha-toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy. 2005;35(8):1088–1095.
   PubMed Web of Science ®Google Scholar
• Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing “T22” T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. J Allergy Clin Immunol. 2009;123(6):1244–1252e1242.
   PubMed Web of Science ®Google Scholar
• Sonkoly E, Muller A, Lauerma AI, et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. J Allergy Clin Immunol. 2006;117(2):411–417.
   PubMed Web of Science ®Google Scholar
• Nakajima S, Kitoh A, Egawa G, et al. IL-17A as an inducer for Th2 immune responses in murine atopic dermatitis models. J Invest Dermatol. 2014;134(8):2122–2130.
   PubMed Web of Science ®Google Scholar
• Reginald K, Westritschnig K, Werfel T, et al. Immunoglobulin E antibody reactivity to bacterial antigens in atopic dermatitis patients. Clin Exp Allergy. 2011;41(3):357–369.
   PubMed Web of Science ®Google Scholar
• Biedermann T, Skabytska Y, Kaesler S, et al. Regulation of T cell immunity in atopic dermatitis by microbes: the Yin and Yang of cutaneous inflammation. Front Immunol. 2015;6:353.
   PubMed Web of Science ®Google Scholar
• Kong HH, Oh J, Deming C, et al. Temporal shifts in the skin microbiome associated with disease flares and treatment in children with atopic dermatitis. Genome Res. 2012;22(5):850–859.
   PubMed Web of Science ®Google Scholar
• Tauber M, Balica S, Hsu CY, et al. Staphylococcus aureus density on lesional and nonlesional skin is strongly associated with disease severity in atopic dermatitis. J Allergy Clin Immunol. 2015. Nov 7;pii: S0091-6749(15)01367-6. [Epub ahead of print]
   PubMed Web of Science ®Google Scholar
• Laborel-Preneron E, Bianchi P, Boralevi F, et al. Effects of the Staphylococcus aureus and Staphylococcus epidermidis Secretomes Isolated from the skin microbiota of atopic children on CD4+ T cell activation. PLoS One. 2015;10(10):e0141067.
   Web of Science ®Google Scholar
• Kobayashi T, Glatz M, Horiuchi K, et al. Dysbiosis and Staphylococcus aureus colonization drives inflammation in atopic dermatitis. Immunity. 2015;42(4):756–766.
   PubMed Web of Science ®Google Scholar
• Roberts SO. Pityrosporum orbiculare: incidence and distribution on clinically normal skin. Br J Dermatol. 1969;81(4):264–269.
   PubMed Web of Science ®Google Scholar
• Gaitanis G, Velegraki A, Mayser P, et al. Skin diseases associated with Malassezia yeasts: facts and controversies. Clin Dermatol. 2013;31(4):455–463.
   PubMed Web of Science ®Google Scholar
• Balaji H, Heratizadeh A, Wichmann K, et al. Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis. J Allergy Clin Immunol. 2011;128(1):92–99e94.
   PubMed Web of Science ®Google Scholar
• Casagrande BF, Fluckiger S, Linder MT, et al. Sensitization to the yeast Malassezia sympodialis is specific for extrinsic and intrinsic atopic eczema. J Invest Dermatol. 2006;126(11):2414–2421.
   PubMed Web of Science ®Google Scholar
• Glatz M, Buchner M, von Bartenwerffer W, et al. Malassezia spp.-specific immunoglobulin E level is a marker for severity of atopic dermatitis in adults. Acta Derm Venereol. 2015;95(2):191–196.
   PubMed Web of Science ®Google Scholar
• Devos SA, van der Valk PG. The relevance of skin prick tests for Pityrosporum ovale in patients with head and neck dermatitis. Allergy. 2000;55(11):1056–1058.
   PubMed Web of Science ®Google Scholar
• Lintu P, Savolainen J, Kortekangas-Savolainen O, et al. Systemic ketoconazole is an effective treatment of atopic dermatitis with IgE-mediated hypersensitivity to yeasts. Allergy. 2001;56(6):512–517.
   PubMed Web of Science ®Google Scholar
• Mayser P, Kupfer J, Nemetz D, et al. Treatment of head and neck dermatitis with ciclopiroxolamine cream–results of a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2006;19(3):153–158.
   PubMed Web of Science ®Google Scholar
• Hradetzky S, Werfel T, Rosner LM. Autoallergy in atopic dermatitis. Allergo J Int. 2015;24(1):16–22.
   PubMedGoogle Scholar
• Schmid-Grendelmeier P, Fluckiger S, Disch R, et al. IgE-mediated and T cell-mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis. J Allergy Clin Immunol. 2005;115(5):1068–1075.
   PubMed Web of Science ®Google Scholar
• Tang TS, Bieber T, Williams HC. Does “autoreactivity” play a role in atopic dermatitis? J Allergy Clin Immunol. 2012;129(5):1209–1215e1202.
   PubMed Web of Science ®Google Scholar
• Valenta R, Seiberler S, Natter S, et al. Autoallergy: a pathogenetic factor in atopic dermatitis? J Allergy Clin Immunol. 2000;105(3):432–437.
   PubMed Web of Science ®Google Scholar
• Mittermann I, Reininger R, Zimmermann M, et al. The IgE-reactive autoantigen Hom s 2 induces damage of respiratory epithelial cells and keratinocytes via induction of IFN-gamma. J Invest Dermatol. 2008;128(6):1451–1459.
   PubMed Web of Science ®Google Scholar
• Heratizadeh A, Mittermann I, Balaji H, et al. The role of T-cell reactivity towards the autoantigen alpha-NAC in atopic dermatitis. Br J Dermatol. 2011;164(2):316–324.
   PubMed Web of Science ®Google Scholar
• Roesner LM. Meeting abstracts P001. Exp Dermatol. 2013;22(3):e1–e55.
   PubMed Web of Science ®Google Scholar
• Hradetzky S, Roesner LM, Heratizadeh A, et al. Differential cytokine induction by the human skin-associated autoallergen thioredoxin in sensitized patients with atopic dermatitis and healthy control subjects. J Allergy Clin Immunol. 2015;135(5):1378–1380 e1371–1375.
   PubMed Web of Science ®Google Scholar
• Hradetzky S, Balaji H, Roesner LM, et al. The human skin-associated autoantigen alpha-NAC activates monocytes and dendritic cells via TLR-2 and primes an IL-12-dependent Th1 response. J Invest Dermatol. 2013;133(9):2289–2292.
   PubMed Web of Science ®Google Scholar
• Hradetzky S, Roesner LM, Balaji H, et al. Cytokine effects induced by the human autoallergen alpha-NAC. J Invest Dermatol. 2014;134(6):1570–1578.
   PubMed Web of Science ®Google Scholar
• Yosipovitch G, Papoiu AD. What causes itch in atopic dermatitis? Curr Allergy Asthma Rep. 2008;8(4):306–311.
   PubMed Web of Science ®Google Scholar
• Mollanazar NK, Smith PK, Yosipovitch G. Mediators of chronic pruritus in atopic dermatitis: getting the itch out? Clin Rev Allergy Immunol. 2015. [Epub ahead of print].
   PubMedGoogle Scholar
• Wilson SR, The L, Batia LM, et al. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013;155(2):285–295.
   PubMed Web of Science ®Google Scholar
• Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3(7):673–680.
   PubMed Web of Science ®Google Scholar
• Le TA, Takai T, Vu AT, et al. Flagellin induces the expression of thymic stromal lymphopoietin in human keratinocytes via toll-like receptor 5. Int Arch Allergy Immunol. 2011;155(1):31–37.
   PubMed Web of Science ®Google Scholar
• Xie Y, Takai T, Chen X, et al. Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes. J Dermatol Sci. 2012;66(3):233–237.
   PubMed Web of Science ®Google Scholar
• Moniaga CS, Jeong SK, Egawa G, et al. Protease activity enhances production of thymic stromal lymphopoietin and basophil accumulation in flaky tail mice. Am J Pathol. 2013;182(3):841–851.
   PubMed Web of Science ®Google Scholar
• Ryu WI, Lee H, Kim JH, et al. IL-33 induces Egr-1-dependent TSLP expression via the MAPK pathways in human keratinocytes. Exp Dermatol. 2015;24(11):857–863.
   PubMed Web of Science ®Google Scholar
• Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med. 2007;204(2):253–258.
   PubMed Web of Science ®Google Scholar
• Nakajima S, Igyarto BZ, Honda T, et al. Langerhans cells are critical in epicutaneous sensitization with protein antigen via thymic stromal lymphopoietin receptor signaling. J Allergy Clin Immunol. 2012;129(4):1048–1055 e1046.
   PubMed Web of Science ®Google Scholar
• Raap U, Weissmantel S, Gehring M, et al. IL-31 significantly correlates with disease activity and Th2 cytokine levels in children with atopic dermatitis. Pediatr Allergy Immunol. 2012;23(3):285–288.
   PubMed Web of Science ®Google Scholar
• Heise R, Neis MM, Marquardt Y, et al. IL-31 receptor alpha expression in epidermal keratinocytes is modulated by cell differentiation and interferon gamma. J Invest Dermatol. 2009;129(1):240–243.
   PubMed Web of Science ®Google Scholar
• Cornelissen C, Marquardt Y, Czaja K, et al. IL-31 regulates differentiation and filaggrin expression in human organotypic skin models. J Allergy Clin Immunol. 2012;129(2):426–433, 433 e421–428.
   PubMed Web of Science ®Google Scholar
• Kato A, Fujii E, Watanabe T, et al. Distribution of IL-31 and its receptor expressing cells in skin of atopic dermatitis. J Dermatol Sci. 2014;74(3):229–235.
   PubMed Web of Science ®Google Scholar
• Cevikbas F, Wang X, Akiyama T, et al. A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: involvement of TRPV1 and TRPA1. J Allergy Clin Immunol. 2014;133(2):448–460.
   PubMed Web of Science ®Google Scholar
• Bilsborough J, Leung DY, Maurer M, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2006;117(2):418–425.
   PubMed Web of Science ®Google Scholar
• Szegedi K, Kremer AE, Kezic S, et al. Increased frequencies of IL-31-producing T cells are found in chronic atopic dermatitis skin. Exp Dermatol. 2012;21(6):431–436.
   PubMed Web of Science ®Google Scholar
• Stott B, Lavender P, Lehmann S, et al. Human IL-31 is induced by IL-4 and promotes TH2-driven inflammation. J Allergy Clin Immunol. 2013;132(2):446–454 e445.
   PubMed Web of Science ®Google Scholar
• Niebuhr M, Mamerow D, Heratizadeh A, et al. Staphylococcal alpha-toxin induces a higher T cell proliferation and interleukin-31 in atopic dermatitis. Int Arch Allergy Immunol. 2011;156(4):412–415.
   PubMed Web of Science ®Google Scholar
• Hwang JS, Kim GC, Park E, et al. NFAT1 and JunB cooperatively regulate IL-31 gene expression in CD4+ T cells in health and disease. J Immunol. 2015;194(4):1963–1974.
   PubMed Web of Science ®Google Scholar
• Bieber T, Vick K, Folster-Holst R, et al. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis. Allergy. 2007;62(2):184–189.
   PubMed Web of Science ®Google Scholar
• Luger T, Boguniewicz M, Carr W, et al. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol. 2015;26(4):306–315.
   PubMed Web of Science ®Google Scholar
• Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part I. J Eur Acad Dermatol Venereol. 2012;26(8):1045–1060.
   PubMed Web of Science ®Google Scholar
• Boralevi F, Saint Aroman M, Delarue A, et al. Long-term emollient therapy improves xerosis in children with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014;28(11):1456–1462.
   PubMed Web of Science ®Google Scholar
• Ring J, Alomar A, Bieber T, et al. Guidelines for treatment of atopic eczema (atopic dermatitis) part II. J Eur Acad Dermatol Venereol. 2012;26(9):1176–1193.
   PubMed Web of Science ®Google Scholar
• Thurmond RL. The histamine H4 receptor: from orphan to the clinic. Front Pharmacol. 2015;6:65.
   PubMed Web of Science ®Google Scholar
• Murata Y, Song M, Kikuchi H, et al. Phase 2a, randomized, double-blind, placebo-controlled, multicenter, parallel-group study of a H4 R-antagonist (JNJ-39758979) in Japanese adults with moderate atopic dermatitis. J Dermatol. 2015;42(2):129–139.
   PubMed Web of Science ®Google Scholar
• Nemoto O, Furue M, Nakagawa H, et al. The first trial of CIM331, a humanized anti-human IL-31 receptor A antibody, for healthy volunteers and patients with atopic dermatitis to evaluate safety, tolerability and pharmacokinetics of a single dose in a randomised, double-blind, placebo-controlled study. Br J Dermatol. 2015;174(2):296–304.
   PubMed Web of Science ®Google Scholar
• Staab D, Diepgen TL, Fartasch M, et al. Age related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ. 2006;332(7547):933–938.
   PubMed Web of Science ®Google Scholar